Friday, January 4, 2013

Defense Authorization Act Creates Hope for Pancreatic Cancer Research

The following text is from this LA Times article


"Deep in the fine print of a $633-billion defense bill signed by President Obama on Wednesday, a provision aimed at the National Cancer Institute may hasten the development of earlier detection and treatment methods for deadly malignancies such as pancreatic cancer.

The Defense Authorization Act signed into law Jan. 2 carried along the Recalcitrant Cancer Research Act, a measure pressed by the Pancreatic Cancer Action Network and the Lung Cancer Alliance to shift the focus of the federal government's cancer research toward malignancies with poor early-detection and low survival rates.

Pancreatic cancer, which will claim the lives of more than 37,000 this year, has the lowest five-year survival rate, at 6%, of any of the major cancers."





Search This Blog

Loading...